Such a gifted "rookie" that the founder of the company gave up part of his personal stock to get him... As for trials Mr. Fadirian probably knows more about trials than any Big Pharma CEO. He's got Missling's back.
So you want to replace Missling, how about that ex-CEO of Biogen that got fired? He has lots of experience and might even be willing to work cheaper. :)
Market Data 
Markets 
AI
